Free Trial
→ Crypto Gets Official Government Backing—Here's the Winner (From Crypto 101 Media) (Ad)tc pixel

MP Advisors Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at MP Advisors. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by MP Advisors.

Brokerage Ranking
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Total Ratings
0 Last 12 Months
Buy Ratings
0 Last 12 Months
Sell Ratings
0 Last 12 Months
United States flag
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$81.07
+0.1%		10/17/2012 Boost Price Target$45.00 ➝ $50.00OutperformView details for MP Advisors rating of Merck & Co., Inc. (NYSE:MRK) on 10/17/2012
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$81.07
+0.1%		7/13/2012 Upgrade$45.00Market Perform ➝ OutperformView details for MP Advisors rating of Merck & Co., Inc. (NYSE:MRK) on 7/13/2012
Amgen Inc. stock logo
AMGN
Amgen
$273.08
-0.5%		5/10/2011 Boost Price Target$63.00 ➝ $65.00OutperformView details for MP Advisors rating of Amgen (NASDAQ:AMGN) on 5/10/2011
Biogen Inc. stock logo
BIIB
Biogen
$143.68
+0.3%		4/15/2011 Upgrade$60.00 ➝ $94.00Market Perform ➝ OutperformView details for MP Advisors rating of Biogen (NASDAQ:BIIB) on 4/15/2011
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$575.06
+0.4%		4/7/2011 Upgrade$36.00 ➝ $54.00Market Perform ➝ OutperformView details for MP Advisors rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/7/2011
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.95
+2.1%		2/24/2011 Initiated Coverage$100.00Market PerformView details for MP Advisors rating of Protalix BioTherapeutics (NYSE:PLX) on 2/24/2011
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$575.06
+0.4%		12/16/2010 Downgrade$34.00 ➝ $34.00Outperform ➝ Market PerformView details for MP Advisors rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 12/16/2010
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$34.98
-6.2%		12/10/2010 DowngradeOutperform ➝ Market PerformView details for MP Advisors rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2010

MarketBeat Community Rating for MP Advisors

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  53,218 (Vote Outperform)
Underperform Votes:  50,787 (Vote Underperform)
Total Votes:  104,005
MarketBeat's community ratings are surveys of what our community members think about MP Advisors and other research firms. Vote "Outperform" if you believe MP Advisors's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MP Advisors's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
Today's Ratings
Top-Rated Stocks
More Ratings Tools